# Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly

> **NCT03312231** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 720 (actual)

## Conditions studied

- Avian Influenza
- Influenza Immunisation

## Interventions

- **DRUG:** AS03
- **BIOLOGICAL:** Inactivated influenza H7N9 vaccine
- **OTHER:** Phosphate Buffered Saline (PBS) diluent

## Key facts

- **NCT ID:** NCT03312231
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-14
- **Primary completion:** 2019-09-26
- **Final completion:** 2019-09-26
- **Target enrollment:** 720 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03312231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03312231, "Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03312231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*